AnovaOS Network Powered Patient Registry

Anova Enterprises, Inc100,000 enrolled

Overview

The objective of this study is the development, implementation and management of a registry of patient data that captures clinically meaningful, real-world, data on the diagnosis, nature, course of infection, treatment(s) and outcomes in patients with complex disease globally.

The AnovaOS™ Network Powered Patient Registry may be used to inform the development and conduct of clinical trials and observational studies designed to better understand, prevent, diagnose, treat, ameliorate or cure disease. The AnovaOS™ Network Powered Patient Registry may additionally be used to expedite identification and recruitment of participants for clinical trials of promising therapeutics and observational studies.

Study Type

OBSERVATIONAL

Enrollment

100,000

Conditions

Infectious Disease Neoplasms Diseases of the Blood and Blood-Forming Organs and Certain Disorders Involving the Immune Mechanism (D50-D89)Endocrine, Nutritional and Metabolic Diseases (E00-E89)Mental and Behavioural Disorders

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * 18 years old or older; * Confirmed positive diagnosis of disease, condition or disorder. This will be self-reported or reported by the patient's provider, advocacy group or other patient representative; * Laboratory or other independent means of confirmation is not required but may be confirmed in clinical trials; * Able to understand and willing to sign the informed consent document; or whose legal representative has given consent to participate in the research per state and Federal requirements; * Willing and able to complete the registry questions or have the instrument(s) completed by an informed proxy; * Anticipated additional follow up with the registry once per year. Exclusion Criteria: * Subjects who do not meet the inclusion criteria for the study; * Subjects who are unable to understand the protocol or unable to provide legally effective informed consent

Outcomes

Primary Outcomes

Assess Natural history

Assessing natural history, including estimating the magnitude of a problem; determining the underlying incidence or prevalence rate of a condition; examining trends of disease over time; assessing service delivery and identifying groups at high risk; and describing and estimating survival;

Time frame: 5 years

Assess Clinical, Cost and/or Comparative Effectiveness

Determining clinical effectiveness, cost effectiveness, or comparative effectiveness of a test or a treatment;

Time frame: 5 years

Assess Safety

Measuring and monitoring safety and harm associated with the use of specific products and treatments, including conducting comparative evaluation of safety and effectiveness;

Time frame: 5 years

Measuring and/or Improving Quality of Care

Measuring or improving quality of care, including conducting programs to measure and/or improve the practice of medicine and/or public health.

Time frame: 5 years

AnovaOS Network Powered Patient Registry

Overview

Conditions

Eligibility

Locations (1)

Outcomes

Primary Outcomes

Central Contacts